Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIRNAOMICS-B

3.720
+0.0300.81%
Volume:110.45K
Turnover:410.86K
Market Cap:391.22M
PE:-0.71
High:3.800
Open:3.580
Low:3.580
Close:3.690
Loading ...

Company Profile

Company Name:
SIRNAOMICS-B
Exchange:
SEHK
Establishment Date:
2007
Employees:
69
Office Location:
Hopewell Centre,46th Floor,183 Queen’s Road East,Wan Chai,Hong Kong
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a sterile drug product for the treatment of nonmelanoma skin cancer (NMSC), including squamous cell carcinoma in situ and basal cell carcinoma (BCC), recurrent keloids after keloidectomy, hypertrophic scar (HTS) and solid liver tumors, as well as for medical aesthetics. Its STP707 is a sterile drug product for the treatment of solid tumors, including liver cancer, metastatic cutaneous squamous-cell skin cancer (cSCC) and non-small cell lung cancer. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead.

Directors

Name
Position
HUANG Meng Ying
Chairman of the Board,Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
PAN Hong Hui
Executive Director,Member of the Nomination Committee
YU Chang Hai
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Audit Committee Member
WANG Yu Shan
Independent Director,Audit Committee Chairman
ZHANG Jian Kang
Director,Member of the Remuneration and Assessment Committee

Shareholders

Name
Position
PAN Hong Hui
CEO
YUAN Run Ting
Corporate Secretary
LONG Zhi Feng
Other Senior Executives
XIE Yong Ji
Other Senior Executives
Wang Edward Yongxiang
Other Senior Executives